-
公开(公告)号:US20140302091A1
公开(公告)日:2014-10-09
申请号:US13300217
申请日:2011-11-18
CPC分类号: A61K39/12 , A61K47/26 , A61K47/36 , A61K47/42 , A61K2039/5254 , A61K2039/55555 , A61K2039/70 , C08G2650/58 , C08L71/02 , C08L2203/02 , C12N7/00 , C12N2710/10051 , C12N2710/10061 , C12N2710/24151 , C12N2710/24161 , C12N2760/16051 , C12N2760/16061 , C12N2760/18411 , C12N2770/24134 , C12N2770/24151 , C12N2770/24161 , C12N2770/36151 , C12N2770/36161 , Y02A50/386 , Y02A50/388 , Y02A50/39 , Y02A50/394 , Y02A50/396
摘要: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
摘要翻译: 本文的实施方案涉及活病毒的组合物和方法。 在某些实施方案中,活的减毒病毒组合物包括但不限于一种或多种活的,减毒的病毒和组合物,以减少活的,减毒的病毒的失活和/或降解。 在其它实施方案中,活的减毒病毒组合物可以是疫苗组合物。 在其它组合物中,活的减毒病毒组合物可包括至少一种碳水化合物,至少一种蛋白质和至少一种用于减少活的,减毒病毒的失活和/或降解的高分子量表面活性剂。
-
公开(公告)号:US08084039B2
公开(公告)日:2011-12-27
申请号:US12098077
申请日:2008-04-04
CPC分类号: A61K39/12 , A61K47/26 , A61K47/36 , A61K47/42 , A61K2039/5254 , A61K2039/55555 , A61K2039/70 , C08G2650/58 , C08L71/02 , C08L2203/02 , C12N7/00 , C12N2710/10051 , C12N2710/10061 , C12N2710/24151 , C12N2710/24161 , C12N2760/16051 , C12N2760/16061 , C12N2760/18411 , C12N2770/24134 , C12N2770/24151 , C12N2770/24161 , C12N2770/36151 , C12N2770/36161 , Y02A50/386 , Y02A50/388 , Y02A50/39 , Y02A50/394 , Y02A50/396
摘要: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
摘要翻译: 本文的实施方案涉及活病毒的组合物和方法。 在某些实施方案中,活的减毒病毒组合物包括但不限于一种或多种活的,减毒的病毒和组合物,以减少活的,减毒的病毒的失活和/或降解。 在其它实施方案中,活的减毒病毒组合物可以是疫苗组合物。 在其它组合物中,活的减毒病毒组合物可包括至少一种碳水化合物,至少一种蛋白质和至少一种用于减少活的,减毒病毒的失活和/或降解的高分子量表面活性剂。
-
公开(公告)号:US20080248551A1
公开(公告)日:2008-10-09
申请号:US12098077
申请日:2008-04-04
CPC分类号: A61K39/12 , A61K47/26 , A61K47/36 , A61K47/42 , A61K2039/5254 , A61K2039/55555 , A61K2039/70 , C08G2650/58 , C08L71/02 , C08L2203/02 , C12N7/00 , C12N2710/10051 , C12N2710/10061 , C12N2710/24151 , C12N2710/24161 , C12N2760/16051 , C12N2760/16061 , C12N2760/18411 , C12N2770/24134 , C12N2770/24151 , C12N2770/24161 , C12N2770/36151 , C12N2770/36161 , Y02A50/386 , Y02A50/388 , Y02A50/39 , Y02A50/394 , Y02A50/396
摘要: Embodiments herein relate to compositions of and methods for live viruses. In certain embodiments, a live, attenuated virus composition includes, but is not limited to, one or more live, attenuated viruses and compositions to reduce inactivation and/or degradation of the live, attenuated virus. In other embodiments, the live, attenuated virus composition may be a vaccine composition. In yet other compositions, a live, attenuated virus composition may include at least one carbohydrate, at least one protein and at least one high molecular weight surfactants for reducing inactivation and/or degradation of the live, attenuated virus.
摘要翻译: 本文的实施方案涉及活病毒的组合物和方法。 在某些实施方案中,活的减毒病毒组合物包括但不限于一种或多种活的,减毒的病毒和组合物,以减少活的,减毒的病毒的失活和/或降解。 在其它实施方案中,活的减毒病毒组合物可以是疫苗组合物。 在其它组合物中,活的减毒病毒组合物可包括至少一种碳水化合物,至少一种蛋白质和至少一种用于减少活的,减毒病毒的失活和/或降解的高分子量表面活性剂。
-
公开(公告)号:US20100144015A1
公开(公告)日:2010-06-10
申请号:US12631629
申请日:2009-12-04
CPC分类号: C12N7/00 , C12N2770/24134 , C12N2770/24151
摘要: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
摘要翻译: 本文的实施方案报告用于诱导和/或加速病毒生长的方法,组合物和用途。 在某些实施方案中,方法,组合物和用途通常涉及用于诱导病毒生长,减少滞后时间和/或增加病毒斑块大小的共聚物组合物。 在其它实施方案中,共聚物组合物的方法,组合物和用途可用于诱导黄病毒生长,减少生长滞后和/或增加斑块大小。
-
公开(公告)号:US08871487B2
公开(公告)日:2014-10-28
申请号:US12631629
申请日:2009-12-04
CPC分类号: C12N7/00 , C12N2770/24134 , C12N2770/24151
摘要: Embodiments herein report methods, compositions and uses for inducing and/or accelerating viral growth. In certain embodiments, methods, compositions and uses generally related to copolymer compositions for inducing viral growth, reducing lag time and/or increasing viral plaque size. In other embodiments, methods, compositions and uses of copolymer compositions can be for inducing flaviviral growth, reducing lag in growth and/or increasing plaque size.
摘要翻译: 本文的实施方案报告用于诱导和/或加速病毒生长的方法,组合物和用途。 在某些实施方案中,方法,组合物和用途通常涉及用于诱导病毒生长,减少滞后时间和/或增加病毒斑块大小的共聚物组合物。 在其它实施方案中,共聚物组合物的方法,组合物和用途可用于诱导黄病毒生长,减少生长滞后和/或增加斑块大小。
-
-
-
-